Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedJun 23, 2026
DataAggregated Company Financials
Companies5
  • 7D0.4%
  • 3M-3.0%
  • 1Y-2.3%
  • YTD-10.5%

In the last week, Pharma has been flat. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 6.2% annually.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 23 Jun 2026NOK 3.4bNOK 1.7b-NOK 23,226,000.0015.6x-146.4x2x
Thu, 21 May 2026NOK 3.7bNOK 1.7b-NOK 23,226,000.0017.1x-160.7x2.1x
Sat, 18 Apr 2026NOK 4.0bNOK 1.6b-NOK 67,842,000.0013.4x-59.5x2.5x
Mon, 16 Mar 2026NOK 3.6bNOK 1.6b-NOK 60,027,434.0012.8x-60.6x2.3x
Wed, 11 Feb 2026NOK 3.5bNOK 1.6b-NOK 67,438,434.00418.3x-52x2.2x
Fri, 09 Jan 2026NOK 3.9bNOK 1.6b-NOK 67,438,434.00488.3x-57.7x2.5x
Sun, 07 Dec 2025NOK 3.6bNOK 1.6b-NOK 67,438,434.00422.3x-53.4x2.3x
Tue, 04 Nov 2025NOK 3.3bNOK 1.6b-NOK 79,791,434.00367.9x-41.3x2.1x
Thu, 02 Oct 2025NOK 3.3bNOK 1.5b-NOK 83,687,434.0013.3x-39.4x2.2x
Sat, 30 Aug 2025NOK 3.5bNOK 1.5b-NOK 121,455,434.0013.9x-28.5x2.3x
Mon, 28 Jul 2025NOK 3.5bNOK 1.5b-NOK 91,864,434.00386.6x-38x2.3x
Wed, 25 Jun 2025NOK 3.3bNOK 1.5b-NOK 115,163,434.00335.8x-28.5x2.1x
Fri, 23 May 2025NOK 3.2bNOK 1.5b-NOK 122,678,000.00320.7x-25.9x2.1x
Sun, 20 Apr 2025NOK 3.2bNOK 1.5b-NOK 129,957,000.00141.3x-24.5x2.1x
Tue, 18 Mar 2025NOK 3.1bNOK 1.5b-NOK 153,695,743.00150.2x-20.4x2.1x
Thu, 13 Feb 2025NOK 3.2bNOK 1.5bNOK 22.4m20.7x143.9x2.2x
Sat, 11 Jan 2025NOK 3.1bNOK 1.5bNOK 22.4m21.9x137x2.1x
Mon, 09 Dec 2024NOK 3.0bNOK 1.5bNOK 22.4m21.6x133.3x2x
Wed, 06 Nov 2024NOK 3.1bNOK 1.5bNOK 34.2m19.7x89.3x2.1x
Fri, 04 Oct 2024NOK 3.2bNOK 1.5bNOK 45.2m22.7x71.6x2.2x
Sun, 01 Sep 2024NOK 3.0bNOK 1.5bNOK 105.8m20.6x28.8x2x
Tue, 30 Jul 2024NOK 3.0bNOK 1.5bNOK 49.7m161.6x60.2x2x
Thu, 27 Jun 2024NOK 3.3bNOK 1.5bNOK 10.2m177.4x321.8x2.2x
Sat, 25 May 2024NOK 3.3bNOK 1.5bNOK 7.6m176.3x430.9x2.2x
Mon, 22 Apr 2024NOK 3.3bNOK 1.5bNOK 7.6m155.9x425.3x2.2x
Wed, 20 Mar 2024NOK 3.2bNOK 1.5bNOK 33.1m159.5x95.8x2.2x
Fri, 16 Feb 2024NOK 3.3bNOK 1.4bNOK 18.6m25.2x179.3x2.3x
Sun, 14 Jan 2024NOK 3.5bNOK 1.4bNOK 18.6m25.1x190.4x2.5x
Tue, 12 Dec 2023NOK 3.3bNOK 1.4bNOK 18.6m23.2x177.4x2.3x
Thu, 09 Nov 2023NOK 3.2bNOK 1.4bNOK 13.8m25x231.7x2.3x
Sat, 07 Oct 2023NOK 3.2bNOK 1.3b-NOK 38,433,125.0053x-83.4x2.4x
Mon, 04 Sep 2023NOK 2.9bNOK 1.3b-NOK 53,836,125.0049x-53.8x2.2x
Wed, 02 Aug 2023NOK 3.1bNOK 1.2b-NOK 60,357,125.0076.9x-50.7x2.5x
Fri, 30 Jun 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0074x-49.2x2.4x
Price to Earnings Ratio

-49.2x


Total Market Cap: NOK 3.0bTotal Earnings: -NOK 60,357,125.00Total Revenue: NOK 1.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 32.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Norwegian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 12% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market-0.87%
Healthcare0.15%
Pharma0.43%
Pharma0.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PHO PhotocureNOK 60.001.7%
+NOK 26.6m
13.2%PE18.9x
ONCIN OncoinventNOK 49.0011.9%
+NOK 23.3m
n/aPS7.8x

Latest News